As an aesthetician, Ina LaRocca is amazing
It slows gastric emptying meaning food leaves the stomach more slowly which extends post-meal fullness
risk of edema, fractures, bladder cancer Non-Insulin Injectable Agents (assign Z79.85): GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide, tirzepatide [dual GIP/GLP-1]): Cardiovascular and renal protective
The three receptors to which retatrutide binds function as follows: GLP-1: Enhances satiety, reduces appetite, and promotes insulin secretion, directly supporting weight loss and blood glucose regulation
For detailed safety data on BPC-157 specifically, see our BPC-157 side effects guide
B12 optimization may complement your existing regimen, but it doesn't replace it, and changes should be coordinated